| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Dumesnil Simon is a Director at Pasithea Therapeutics Corp.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $28K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | KTTA Pasithea Therapeutics Corp. | Director | Buy | 33,333 | $0.75 | $24,999.75 | +1,333% | -43.3% | - |